Climb Bio, Inc. (CLYM) stock
CLYMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.30−0.48 (-4.91%)
Close on Nov 18, 2026Market cap $534.16MP/E –Yield –
Climb Bio market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Climb Bio's market cap was $703.59M on Nov 11, 2026, against $128.87M a year earlier. Over the last 5 years it ranged from $68.01M to $788.60M, with a median of $121.00M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $703.59M | +158.0% |
| 2025 | Dec 31, 2025 | $272.74M | +125.4% |
| 2024 | Dec 31, 2024 | $121.00M | +63.2% |
| 2023 | Dec 29, 2023 | $74.16M | -23.9% |
| 2022 | Dec 30, 2022 | $97.50M | -64.4% |
| 2021 | Dec 31, 2021 | $274.04M | – |
See a number that looks wrong?